BACKGROUND: Schizophrenia is associated with significant economic burden. In Brazil, antipsychotic drugs and outpatient and hospital services are provided by the Brazilian National Health System (SUS) for patients with schizophrenia. However, few studies capture the cost of managing these patients within the Brazilian NHS. This is important to appraise different management approaches within universal healthcare systems. OBJECTIVE: Our objective was to use real-world data to describe the costs associated with the treatment of schizophrenia in adults receiving atypical antipsychotics in Brazil from 2000 to 2010. METHODS: We integrated three national databases for adult patients with schizophrenia receiving one or more atypical antipsychoti...
Objective: To explore the direct and Indirect costs in a cohort of 225 risperidone-treated patients ...
The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance the...
OBJETIVO: Estimar o custo direto da esquizofrenia para o setor p\ufablico. M\uc9TODOS: O estudo foi ...
Background: Schizophrenia is associated with significant economic burden. In Brazil, antipsychotics ...
Guidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, the rate of ...
Guidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, the rate of ...
Aims: Significant cost is associated with schizophrenia and relapses are one significant cost elemen...
Obiective: To evaluate the direct medical cost of atypical antipsychotic therapy for schizophrenia a...
Cost-effectiveness of treatment of schizophrenia with typical and atypical antipsychotics Introduct...
IntroductionGuidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, ...
The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy with anti...
Background: Cost-of-illness (COI) studies provide useful information on the economic burden that sch...
The economic impact of serious conditions such as schizophrenia is felt widely. The impact on overal...
Objective: To assess from a health sector perspective the incremental cost-effectiveness of eight dr...
Objective: To examine both schizophrenia-related costs and total (schizophrenia plus non-schizophren...
Objective: To explore the direct and Indirect costs in a cohort of 225 risperidone-treated patients ...
The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance the...
OBJETIVO: Estimar o custo direto da esquizofrenia para o setor p\ufablico. M\uc9TODOS: O estudo foi ...
Background: Schizophrenia is associated with significant economic burden. In Brazil, antipsychotics ...
Guidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, the rate of ...
Guidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, the rate of ...
Aims: Significant cost is associated with schizophrenia and relapses are one significant cost elemen...
Obiective: To evaluate the direct medical cost of atypical antipsychotic therapy for schizophrenia a...
Cost-effectiveness of treatment of schizophrenia with typical and atypical antipsychotics Introduct...
IntroductionGuidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, ...
The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy with anti...
Background: Cost-of-illness (COI) studies provide useful information on the economic burden that sch...
The economic impact of serious conditions such as schizophrenia is felt widely. The impact on overal...
Objective: To assess from a health sector perspective the incremental cost-effectiveness of eight dr...
Objective: To examine both schizophrenia-related costs and total (schizophrenia plus non-schizophren...
Objective: To explore the direct and Indirect costs in a cohort of 225 risperidone-treated patients ...
The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance the...
OBJETIVO: Estimar o custo direto da esquizofrenia para o setor p\ufablico. M\uc9TODOS: O estudo foi ...